c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms

被引:246
作者
Ho, IC
Lo, D
Glimcher, LH
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Immunol & Rheumatol, Boston, MA 02115 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
interleukin; 4; T helper cells; c-maf; transcription factor;
D O I
10.1084/jem.188.10.1859
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The c-maf protooncogene is a T helper cell type 2 (Th2)-specific transcription factor that activates the interleukin (IL)-4 promoter in vitro. Although it has been postulated that c-mai directs the Th2-specific expression of the IL-4 gene in vivo, direct evidence that c-maf functions during the differentiation of normal, primary T cells is lacking. We now demonstrate that overexpression of c-maf in vivo skews the Th immune response along a Th2 pathway, as evidenced by increased production of Th2 cytokines and the IL-4-dependent immunoglobulins, IgG1 and IgE. The overproduction of IgG1 and IgE in the CD4 promoter/c-maf transgenic mice was IL-4 dependent since this was not observed in c-maf transgenic mice bred onto an IL-4-deficient background. Ectopic expression of c-maf in mature Th1 cells did not confer on them the ability to produce IL-4, bur did decrease the production of IFN-gamma. The attenuation of Th1 differentiation by c-maf overexpression occurred by a mechanism that was independent of IL-4 and other Th2 cytokines, and could be overcome by IL-12. These studies demonstrate that c-maf promotes Th2 differentiation by IL-4-dependent mechanisms and attenuates Th1 differentiation by Th2 cytokine-independent mechanisms.
引用
收藏
页码:1859 / 1866
页数:8
相关论文
共 35 条
  • [1] Functional diversity of helper T lymphocytes
    Abbas, AK
    Murphy, KM
    Sher, A
    [J]. NATURE, 1996, 383 (6603) : 787 - 793
  • [2] Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism
    Arreaza, GA
    Cameron, MJ
    Jaramillo, A
    Gill, BM
    Hardy, D
    Laupland, KB
    Rapoport, MJ
    Zucker, P
    Chakrabarti, S
    Chensue, SW
    Qin, HY
    Singh, B
    Delovitch, TL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) : 2243 - 2253
  • [3] Bancroft AJ, 1998, J IMMUNOL, V160, P3453
  • [4] Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses
    Barner, M
    Mohrs, M
    Brombacher, F
    Kopf, M
    [J]. CURRENT BIOLOGY, 1998, 8 (11) : 669 - 672
  • [5] The Maf transcription factors: regulators of differentiation
    Blank, V
    Andrews, NC
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1997, 22 (11) : 437 - 441
  • [6] B-CELL STIMULATORY FACTOR-I INTERLEUKIN-4 MESSENGER-RNA IS EXPRESSED BY NORMAL AND TRANSFORMED MAST-CELLS
    BROWN, MA
    PIERCE, JH
    WATSON, CJ
    FALCO, J
    IHLE, JN
    PAUL, WE
    [J]. CELL, 1987, 50 (05) : 809 - 818
  • [7] HUMAN PERIPHERAL-BLOOD BASOPHILS PRIMED BY INTERLEUKIN-3 (IL-3) PRODUCE IL-4 IN RESPONSE TO IMMUNOGLOBULIN-E-RECEPTOR STIMULATION
    BRUNNER, T
    HEUSSER, CH
    DAHINDEN, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) : 605 - 611
  • [8] Crawford R M, 1988, Adv Exp Med Biol, V239, P223
  • [9] CRAWFORD RM, 1987, J IMMUNOL, V139, P135
  • [10] DAVYDOV IV, 1995, J IMMUNOL, V155, P5273